The near genome-wide associations of ACVRL1 and TBX4 are considered positive controls in our study as variants in ACVRL1 are enriched in PVOD/PCH patients and variants in TBX4 enriched in pediatric patients, both subgroups included in the cohort but at very low frequency. Here, ACVRL1 is linked to pulmonary venoocclusive disease.